Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
Melanoma
Interventions
BIOLOGICAL

naked DNA coding for protein AMEP

injections 28days interval of 3 increasing doses of plasmid with electrotransfer

Trial Locations (4)

54511

CHU Nancy Hôpital Brabois, Vandœuvre-lès-Nancy

75010

Hôpital Saint Louis. Service de dermatologie, Paris

94805

Gustave Roussy Institute,, Le Kremlin-Bicêtre

SI-1000

Institute of Oncology Ljubljana, Ljubljana

Sponsors
All Listed Sponsors
lead

Valerio Therapeutics

INDUSTRY

NCT01764009 - Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma | Biotech Hunter | Biotech Hunter